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whether the first case of MPLCs was described by Beyreuther
in 1924, as mentioned by Okada and colleagues,1 or whether
the first case was described in 1928, as pointed out by
Chaudhuri.5
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Reply to the Editor:
It is our pleasure to address the points raised by Ytldtzeli
and associates in their letter regarding our recently published
article. l We had already assessed the characteristics of small
non-small cell lung cancers with DNA ploidy. This study con-
sisted of 39% aneuploidy and 61 % diploidy tumors and sug-
gested that DNA ploidy was a prognostic factor and that ane-
uploidy possessed occult malignancy.2 However, we do not
think that the DNA ploidy is the definitive answer to the
dilemma whether a tumor is a second primary or a recurrence.
When the 2 tumors had completely different patterns of DNA
ploidy, they were defined as second primaries. However, as
shown in many previous reports,3-5 all specimens had normal
(diploid) peaks, which were made by tumor cells and normal
epithelial or stromal cells (or both) within tumors. Even with
cytofluorometric evaluation of lung cancer, which can theo-
retically select only tumor cells, most tumors contained nor-
mal peaks.6 Therefore we have speculated on the sensitivity
and specificity of the ploidy results regarding the differentia-
tion between second primaries and metastases. We have fol-
lowed the policy that lung-saving procedures such as bron-
choplasty for a primary lesion must always be kept in mind.
Of 671 patients who underwent operations for primary lung
cancer over a period of 6 years, we considered 39 patients to
have pT2 Nl MO disease. None was subjected to pneu-
monectomy, and 14 (36%) underwent sleeve lobectomy
instead. We succeeded in preserving lung function with a rea-
sonable prognosis and a better postoperative quality of life,
which was proven by spirometry and treadmill exercise
test.7,8 Needless to say, pneumonectomy decreases the chance
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of a second primary significantly compared with lobectomy,
because removal of more lung tissue with the first tumor
would leave the patient with less lung tissue in which a sec-
ond primary could develop later, Preservation of lung func-
tion, however, is much more important than the risk of second
primary lesions.
A smoking index (cigarettes/day x years) of more than 600
at the time of diagnosis of the second tumor was recorded in
43 patients (75%), suggesting a remarkable incidence of
smoking among patients with multiple primary tumors. This
probably accounts for the high proportion of squamous cell
carcinomas in our series.
Chaudhuri,9 like us, 1 mentioned that Beyreuther described
the first case of multiple primary lung cancer in 1924.
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Profound systemic hypothermia and release of
neurotransmitter amino acids
To the Editor:
We read with great interest the article titled "Profound
Systemic Hypothermia Inhibits the Release of Neuro-
transmitter Amino Acids in Spinal Cord Ischemia" by Rokkas
and associates (J Thorac Cardiovasc Surg 1995;110:27-35).
Although considerable information is provided, we believe it
needs to be placed in the proper perspective to lead to a cor-
